Jianting Du

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Neuropathic Pain

Small Cell Lung Cancer

Neoadjuvant Chemotherapy

Top Venues

Thoracic cancer

International journal of general medicine

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jianting Du, Shuliang Zhang, Xiaodan Zhang, Zhang Yang, Songtao Xue, Guobing Xu, Bin Zheng, Chun Chen
miR-1301-3p promotes invasion and migration and EMT progression in esophageal cancer by downregulating NBL1 expression. Thoracic cancer (2023)
Xiwen Zhou, Jianting Du, Guobing Xu, Chun Chen, Bin Zheng, Jiahe Chen
Cost-effectiveness of osimertinib versus placebo in resected EGFR-mutated non-small cell lung cancer in China. Cancer medicine (2022)
Guobing Xu, Jianting Du, Jiarong Zhang, Hao Chen, Bin Zheng, Zhang Yang, Chun Chen
A propensity sore-matched study: Applying a modified chest tube drainage strategy in rapid rehabilitation following uni-portal thoracoscopic pulmonary wedge resection. Thoracic cancer 13 (11) (2022)
Jianting Du, Guobing Xu, Zhang Yang, Bin Zheng, Chun Chen
Pericancerous lymph node imaging with indocyanine green-guided near-infrared fluorescence in radical esophagectomy: Protocol for a single-center, prospective, randomized controlled clinical trial. Thoracic cancer 13 (15) (2022)
Jianting Du, Jiekun Qian, Bin Zheng, Guobing Xu, Hao Chen, Chun Chen
miR-21-5p is a Biomarker for Predicting Prognosis of Lung Adenocarcinoma by Regulating PIK3R1 Expression. International journal of general medicine 14 (2021)